ACADIA PHARMACEUTICALS INC.

ACAD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-45.1M
Depreciation & Amortization
Depreciation $1.1M
Amortization
Stock-Based Compensation $2.1M
Net Cash from Operating Activities $-13.7M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $9.4M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $1.2M
Net Change in Cash $-3.0M
Free Cash Flow
← Newer Page 3 of 3 Older →